Long- term outcome after neoadjuvant radiochemotherapy in locally advanced non-inflammatory breast cancer and predictive factors for a pathologic complete remission; results of a multi-variate analysis

被引：0
|
作者：
Matuschek, C.
Boelke, E.
Roth, S.
Bojar, H.
Audretsch, W.
Janni, J. W.
Nestle-Kraemling, C.
Sauer, R.
Speer, V.
Budach, W.
机构：
[1] Univ Dusseldorf, Dusseldorf, Germany
[2] European Inst Mol Oncol, Dusseldorf, Germany
[3] Marien Hosp, Dusseldorf, Germany
[4] Krankenhaus Gerresheim, Dusseldorf, Germany
[5] Univ Erlangen Nurnberg, Erlangen, Germany
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/0008-5472.SABCS12-P1-14-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-14-04
引用
收藏
页数：1
相关论文
共 43 条
  • [31] Correlation of various pathologic complete response (pCR) definitions with long-term outcome and the prognostic value of pCR in various breast cancer subtypes: Results from the German neoadjuvant meta-analysis
    Von Minckwitz, G.
    Kaufmann, M.
    Kuemmel, S.
    Fasching, P. A.
    Eiermann, W.
    Blohmer, J. U.
    Costa, S. D.
    Hilfrich, J.
    Jackisch, C.
    Gerber, B.
    Du Bois, A.
    Huober, J. B.
    Hanusch, C. A.
    Konecny, G. E.
    Fett, W.
    Stickeler, E.
    Harbeck, N.
    Mehta, K.
    Loibl, S.
    Untch, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [32] Trial-level prediction of long-term outcome based on pathologic complete response (pCR) after neoadjuvant chemotherapy for early-stage breast cancer (EBC)
    Nekljudova, Valentina
    Loibl, Sibylle
    von Minckwitz, Gunter
    Schneeweiss, Andreas
    Gluck, Stefan
    Crane, Richard
    Li, Huiling
    Luo, Xiaolong
    CONTEMPORARY CLINICAL TRIALS, 2018, 71 : 194 - 198
  • [33] ASO Visual Abstract: The Predictive Utility of MammaPrint and BluePrint in Identifying Patients with Locally Advanced Breast Cancer Who are Most Likely to have Nodal Downstaging and a Pathologic Complete Response After Neoadjuvant Chemotherapy
    Peter Blumencranz
    Mehran Habibi
    Steve Shivers
    Geza Acs
    Lisa E. Blumencranz
    Erin B. Yoder
    Bastiaan van der Baan
    Andrea R. Menicucci
    Patricia Dauer
    William Audeh
    Charles E. Cox
    Annals of Surgical Oncology, 2024, 31 : 393 - 394
  • [34] ASO Visual Abstract: The Predictive Utility of MammaPrint and BluePrint in Identifying Patients with Locally Advanced Breast Cancer Who are Most Likely to have Nodal Downstaging and a Pathologic Complete Response After Neoadjuvant Chemotherapy
    Blumencranz, Peter
    Habibi, Mehran
    Shivers, Steve
    Acs, Geza
    Blumencranz, Lisa E.
    Yoder, Erin B.
    van der Baan, Bastiaan
    Menicucci, Andrea R.
    Dauer, Patricia
    Audeh, William
    Cox, Charles E.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : 393 - 394
  • [35] Is pathological complete response after a trimodality therapy, a predictive factor of long-term survival in locally-advanced esophageal cancer? Results of a retrospective monocentric study
    Francoual, J.
    Lebreton, G.
    Bazille, C.
    Galais, M. P.
    Dupont, B.
    Alves, A.
    Lubrano, J.
    Morello, R.
    Menahem, B.
    JOURNAL OF VISCERAL SURGERY, 2018, 155 (05) : 365 - 374
  • [36] Pathologic complete response after induction therapy and surgery is an independed long-term survival prognostic factor in locally advanced non-small cell lung cancer
    Schreiner, W.
    Dudek, W.
    Lettmaier, S.
    Rieker, R.
    Fietkau, R.
    Sirbu, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 107 - 107
  • [37] Correction: Is Pathologic Complete Response a Good Predictor for the Long-Term, Clinical Outcome in Patients with Gastric Cancer After Neoadjuvant Chemotherapy? A Retrospective, Multi-institution Study in China
    Chao Lin
    Junjun Ma
    Chunchao Zhu
    Xuan Zhao
    Yueda Chen
    Lu Zang
    Fenglin Liu
    Annals of Surgical Oncology, 2023, 30 : 5563 - 5563
  • [38] Fifteen-year results of a randomized prospective trial comparing hyperfractionated versus once-daily chest wall radiation after chemotherapy and mastectomy for patients with locally advanced non-inflammatory breast cancer
    Buchholz, TA
    Strom, EA
    Oswald, MJ
    Perkins, GH
    Oh, JL
    Domain, D
    Singletary, SE
    Buzdar, AU
    Hortobagyi, GN
    McNeese, MD
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S235 - S235
  • [39] Comparison of pCR and mediastinal Downstaging as a Surrogate Marker for Long Term-Survival of Patients with locally advanced non-small cell Lung Cancer (NSCLC) after neoadjuvant RadioChemotherapy (CT/RT) and Resection (Trimodality)
    Poettgen, C.
    Graupner, B.
    Theegarten, D.
    Gauler, T.
    Freitag, L.
    Abu Jawad, J.
    Gkika, E.
    Wohlschlaeger, J.
    Welter, S.
    Hoiczyk, M.
    Schuler, M.
    Stamatis, G.
    Eberhardt, W.
    Stuschke, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 : 17 - 17
  • [40] Is adjuvant chemotherapy necessary for patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery in locally advanced rectal cancer? Long-term analysis of 40 ypCR patients at a single center
    Jiaolin Zhou
    Huizhong Qiu
    Guole Lin
    Yi Xiao
    Bin Wu
    Wenming Wu
    Xiyu Sun
    Junyang Lu
    Guannan Zhang
    Lai Xu
    Yuchao Liu
    International Journal of Colorectal Disease, 2016, 31 : 1163 - 1168
12345